Jing Xu

1PUBLICATIONS
16CO-AUTHORS
Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 16, 2025
Phase I/II Study of Tifcemalimab, an Anti-B- and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung Cancer.

Ying Cheng, Jie Wang, Yan Yu

Pageof 1

Frequent Collaborators

1 joint publications

Ying Cheng

1 joint publications

Jie Wang

1 joint publications

Yan Yu

1 joint publications

QiMing Wang